Biotechnology Industry | Healthcare Sector | Dr. Yang Gao CEO | XSHE Exchange | CNE000000PN7 ISIN |
CN Country | 1,448 Employees | - Last Dividend | 1 Sep 2006 Last Split | 2 Apr 1997 IPO Date |
Berry Genomics Co.,Ltd is a pioneering life science and genomics company based in Beijing, China, established in 1997. It specializes in the development and commercialization of genetic testing technologies for clinical applications across China. Berry Genomics provides a comprehensive suite of services and products, catering to the needs of hospitals, research institutions, universities, and enterprises not only throughout Mainland China but also in Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company leverages advanced genetic testing and sequencing technologies to offer innovative solutions in non-invasive DNA prenatal testing, genetic disease testing, and tumor genetic testing, alongside providing cutting-edge laboratory solutions and big data services to further scientific research and healthcare.